Most likely. Nothing is guaranteed, but, I'm expecting double digits in 2015. Especially, if any of the Brilacidin arms show a % effectiveness that was equal to Daptomycin in absolute terms. If so, I'd look for triple in a few years.
In Reply to 'optionking'
Is this a double digits stock in 2015 ?
I am assuming date for Ph1 of Kevertin should be coming soon too...thnx
Market Data 
Markets 
AI
